COYA
Income statement / Annual
Last year (2024), Coya Therapeutics, Inc.'s total revenue was $3.55 B,
an increase of 59,112.58% from the previous year.
In 2024, Coya Therapeutics, Inc.'s net income was -$14.88 M.
See Coya Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$3.55 B |
$6.00 M |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$27,361.00
|
$27,361.00
|
$16,133.00
|
$0.00
|
| Gross Profit |
$3.55 B
|
$5.97 M
|
-$27,361.00
|
-$16,133.00
|
$0.00
|
| Gross Profit Ratio |
1
|
1
|
0
|
0
|
0
|
| Research and Development Expenses |
$11.87 B
|
$6.04 M
|
$4.94 M
|
$2.54 M
|
$248,969.00
|
| General & Administrative Expenses |
$8.89 B
|
$7.83 M
|
$4.85 M
|
$2.31 M
|
$668,700.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$445,131.00
|
| Selling, General & Administrative Expenses |
$8.89 B
|
$7.83 M
|
$4.85 M
|
$2.31 M
|
$445,800.00
|
| Other Expenses |
$52.36 M
|
$0.00
|
$27,361.00
|
$16,133.00
|
$0.00
|
| Operating Expenses |
$20.80 B
|
$13.91 M
|
$9.81 M
|
$4.87 M
|
$694,769.00
|
| Cost And Expenses |
$20.80 B
|
$13.91 M
|
$9.81 M
|
$4.87 M
|
$694,769.00
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$58.46
|
| Interest Expense |
$0.00
|
$0.00
|
$2.43 M
|
$0.00
|
$38,976.00
|
| Depreciation & Amortization |
$27,361.00
|
$27,361.00
|
$27,361.00
|
$16,133.00
|
$704,654.00
|
| EBITDA |
-$17.22 M |
-$7.88 M |
-$12.22 M |
-$4.85 M |
$10,435.00 |
| EBITDA Ratio |
-0
|
-1.31
|
0
|
0
|
0
|
| Operating Income Ratio |
-4.85
|
-1.32
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$3.09 B
|
$639,365.00
|
-$2.43 M
|
-$21,482.00
|
-$38,426.00
|
| Income Before Tax |
-$14.16 B
|
-$7.26 M
|
-$12.24 M
|
-$4.89 M
|
-$733,195.00
|
| Income Before Tax Ratio |
-3.98
|
-1.21
|
0
|
0
|
0
|
| Income Tax Expense |
$720.29 M
|
$723,852.00
|
$2.43 M
|
-$21,482.00
|
-$704.65
|
| Net Income |
-$14.88 M
|
-$7.99 M
|
-$14.68 M
|
-$4.87 M
|
-$733,195.00
|
| Net Income Ratio |
-0
|
-1.33
|
0
|
0
|
0
|
| EPS |
-0.98 |
-0.79 |
-1.48 |
-0.5 |
-0.0757 |
| EPS Diluted |
-0.98 |
-0.79 |
-1.48 |
-0.5 |
-0.0757 |
| Weighted Average Shares Out |
$15.24 M
|
$10.16 M
|
$9.95 M
|
$9.68 M
|
$9.68 M
|
| Weighted Average Shares Out Diluted |
$15.24 M
|
$10.16 M
|
$9.95 M
|
$9.68 M
|
$9.68 M
|
| Link |
|
|
|
|
|
